Financials

  • Market Capitalization 398.58 M
  • Employee 78
  • Founded 2018
  • CEO N/A
  • Website www.centurytx.com
  • Headquarter Delaware, United States
  • FIGI BBG00PM8N5W0
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.11
Relación precio/flujo de caja
0.79

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3093
RCKT
Rocket Pharmaceuticals, Inc. - Common Stock
3.70 USD-0.54%-8.19%+31.67%+21.31%404.02 M USD
3107
ENTA
Enanta Pharmaceuticals, Inc. - Common Stock
13.49 USD-1.10%-5.80%+12.89%+93.54%392.27 M USD
3122
LRMR
Larimar Therapeutics, Inc. - Common Stock
3.71 USD-0.54%+10.09%+5.70%+5.70%385.41 M USD
3132
AVIR
Atea Pharmaceuticals, Inc. - common stock
4.66 USD-1.69%-6.24%+4.48%+45.17%372.93 M USD

Noticias